Does Medicaid Affect Health? Part II
The “intent to treat” format does not alleviate selection problems within the “intent to treat” group.
(Caution – this piece is wonkish.)
An interesting aspect of the Oregon Health Study, which I wrote about a little while ago, is that it uses the “intent to treat” format of a randomized controlled trial. In this kind of study, the control group and treatment group are still randomized. The people in the treatment group, however, don’t necessarily receive the treatment; they just get the opportunity (or have the “intent”) to receive it. This has deep implications for the study’s results.
People who were randomized into the “intent to treat” group got the chance to enroll in Oregon’s Medicaid program. Not all of them signed up. If there were any uniform differences between the people who signed up and those who didn’t, it would have affected the study’s results. I think there probably were, and they did.
Who were the people most likely to sign up for Medicaid, given the chance? I’d guess they fell into two groups: 1) people who cared a lot about their health and seized the opportunity to get insurance, and 2) people who were really sick and knew they needed health care. In other words, the healthiest and sickest people may have been the ones who signed up.
A few months after the lottery, the researchers checked to see whether people with Medicaid coverage had better scores in cholesterol, blood pressure, and other health tests. They didn’t find much of a difference in several areas.
I don’t think this is surprising, if you believe my story about self-selection and adverse selection in the previous paragraph. The healthiest people were already doing everything to be healthy, and the sickest may have been too sick to improve in such a short period of time. The people who might have shown a change even over a few months may have been the least likely to sign up for Medicaid, even when they had the chance.
The “intent to treat” format does not alleviate selection problems within the “intent to treat” group. As the researchers’ appendix explains, it simply magnifies the effect measured for the selected subset of the group. Until they reveal more about the initial health differences between the two subsets of the “intent to treat” group, I’ll have a hard time believing their results.
Image courtesy of Shutterstock
What can 3D printing do for medicine? The "sky is the limit," says Northwell Health researcher Dr. Todd Goldstein.
- Medical professionals are currently using 3D printers to create prosthetics and patient-specific organ models that doctors can use to prepare for surgery.
- Eventually, scientists hope to print patient-specific organs that can be transplanted safely into the human body.
- Northwell Health, New York State's largest health care provider, is pioneering 3D printing in medicine in three key ways.
Beyond Beef sizzles and marbleizes just like real beef, Beyond Meat says.
- Shares of Beyond Meat opened at around $200 on Tuesday morning, falling to nearly $170 by the afternoon.
- Wall Street analysts remain wary of the stock, which has been on a massive hot streak since its IPO in May.
- Beyond Meat faces competition from Impossible Foods and, as of this week, Tyson.
Average waiting time for hitchhikers in Ireland: Less than 30 minutes. In southern Spain: More than 90 minutes.
- A popular means of transportation from the 1920s to the 1980s, hitchhiking has since fallen in disrepute.
- However, as this map shows, thumbing a ride still occupies a thriving niche – if at great geographic variance.
- In some countries and areas, you'll be off the street in no time. In other places, it's much harder to thumb your way from A to B.
A recent study used data from the Big Five personality to estimate psychopathy prevalence in the 48 contiguous states and Washington, D.C.
- The study estimated psychopathy prevalence by looking at the prevalence of certain traits in the Big Five model of personality.
- The District of Columbia had the highest prevalence of psychopathy, compared to other areas.
- The authors cautioned that their measurements were indirect, and that psychopathy in general is difficult to define precisely.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.